Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PFE vs GSK✓SelectedUSD · GSKPFE vs GSK performance historyLatest closeAs of-1.44%11/18
Stock and ETF performance explorer

PFE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+48.7%
GSK return
+101.2%
Excess return
-52.5%
Maximum drawdown
-59.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.4%-1.3%-0.1%-0.8%
7D-4.7%-3.1%-1.6%-3.3%
30D-3.3%-0.9%-2.4%-3.0%
3M+4.5%-4.2%+8.6%+6.3%
6M+14.4%-1.6%+16.0%+14.8%
YTD+20.2%+2.6%+17.6%+17.5%
1Y+17.6%+6.2%+11.4%+13.1%
3Y+13.9%+55.0%-41.1%-10.5%
5Y-28.5%+42.8%-71.3%-42.5%
10Y+48.7%+102.1%-53.5%-3.0%
All+48.7%+101.2%-52.5%-3.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling